Differential expression of miRNAs related to autophagy pathway in tissue and serum samples of colorectal cancer patients

被引:1
|
作者
Umit, Yilmaz [1 ,2 ]
Nesibe, Yilmaz [1 ,3 ]
Kevser, Tanbek [2 ,4 ]
Arzu, Ergen [1 ]
Nihat, Aksakal [5 ]
Umit, Zeybek [1 ]
机构
[1] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Mol Med, Istanbul, Turkey
[2] Inonu Univ, Fac Med, Dept Physiol, Malatya, Turkey
[3] Inonu Univ, Fac Med, Dept Anat, Malatya, Turkey
[4] Inonu Univ, Fac Med, Dept Biochem, Malatya, Turkey
[5] Istanbul Univ, Istanbul Fac Med, Dept Gen Surg, Istanbul, Turkey
关键词
colorectal cancer; autophagy; beclin-1; miRNA; biomarker; DOWN-REGULATION; TUMOR-SUPPRESSOR; EMERGING ROLES; INVASION; MIR-216B; METASTASIS; MIGRATION; CELLS; RADIOSENSITIVITY; OVEREXPRESSION;
D O I
10.4149/BLL_2022_102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: This study was aimed to investigate the relationship of miR-17-5p, miR-30b, miR-30d, miR-216a and miR-216b associated with autophagy gene beclin 1, and beclin 1 gene with colorectal cancer (CRC).MATERIALS AND METHODS: Forty-seven patients with CRC and 50 healthy individuals with no cancer history were included in this study. In the serum, tumor and non-tumoral tissue samples of the CRC patients, and in the serum samples of the healthy subjects, expression levels of miRNAs were detected by qRT-PCR. The beclin 1 gene expression levels were determined by qRT-PCR, and protein levels were determined by Western blot method in tumor and non-tumor tissue samples of the patients.RESULTS: The miR-17-5p and miR-30d expressions were found to be higher in tumor tissue as compared to patient non-tumor tissues, while expressions of beclin-1, miR-30b and miR-216a were found to be lower. In addition, the beclin-1 protein levels were significantly decreased in the tumor tissue as compared to those in the patient non-tumor tissues. The miR-30d expression was significantly reduced in the serum of the patients when the serum samples of CRC patients and healthy controls were compared.CONCLUSION: The beclin 1 gene may play a role as a tumor suppressor in CRC. Moreover, these miRNAs cannot be used as highly reliable biomarkers in serum for CRC diagnosis (Tab. 2, Fig. 6, Ref. 46). Text in PDF www.elis.sk
引用
收藏
页码:634 / 640
页数:7
相关论文
共 50 条
  • [31] Hyaluronidases in colorectal cancer tissue samples
    Bouga, E.
    Bounias, D.
    Kyriakopoulou, D.
    Stavropoulos, M.
    Papageorgakopoulou, N.
    Theocharis, D. A.
    FEBS JOURNAL, 2010, 277 : 197 - 198
  • [32] Differential expression and functions of miRNAs in bladder cancer
    Huang, Hao
    Pi, Xiaowu
    Xin, Chenqi
    Gong, Chen
    Guo, Feng
    Wang, Yang
    Xiong, Ying
    ONCOLOGIE, 2023, 25 (01) : 1 - 15
  • [33] Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing
    Hamfjord, Julian
    Stangeland, Astrid M.
    Hughes, Timothy
    Skrede, Martina L.
    Tveit, Kjell M.
    Ikdahl, Tone
    Kure, Elin H.
    PLOS ONE, 2012, 7 (04):
  • [34] Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer
    Koustas, Evangelos
    Sarantis, Panagiotis
    Theoharis, Stamatios
    Saetta, Angelica A.
    Chatziandreou, Ilenia
    Kyriakopoulou, Georgia
    Giannopoulou, Ioanna
    Michelli, Maria
    Schizas, Dimitrios
    Papavassiliou, Athanasios G.
    Karamouzis, Michalis V.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (10): : 767 - 776
  • [35] Differential expression of exosomal miRNAs between breast cancer patients with recurrence and norecurrence
    Sueta, A.
    Yamamoto, Y.
    Tomiguchi, M.
    Takeshita, T.
    Ibusuki, M.
    Iwase, H.
    CANCER RESEARCH, 2017, 77
  • [36] Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence
    Sueta, Aiko
    Yamamoto, Yutaka
    Tomiguchi, Mai
    Takeshita, Takashi
    Yamamoto-Ibusuki, Mutsuko
    Iwase, Hirotaka
    ONCOTARGET, 2017, 8 (41) : 69934 - 69944
  • [37] The gut microflora assay in patients with colorectal cancer: in feces or tissue samples?
    Rezasoltani, Sama
    Dabiri, Hossein
    Asadzadeh-Aghdae, Hamid
    Sepahi, Abbas Akhavan
    Modarressi, Mohammad Hossein
    Nazemalhosseini-Mojarad, Ehsan
    IRANIAN JOURNAL OF MICROBIOLOGY, 2019, 11 (01) : 1 - 6
  • [38] miRNAs as biomarkers for management of patients with colorectal cancer
    Manne, Upender
    Shanmugam, Chandrakumar
    Bovell, Liselle
    Katkoori, Venkat R.
    Bumpers, Harvey L.
    BIOMARKERS IN MEDICINE, 2010, 4 (05) : 761 - 770
  • [39] Tissue and Serum Galectin-1 Expression in Patients with Colorectal Carcinoma
    Sheng, Tong-Hua
    Rong, Lai-Xiao
    Li, Zhang-Ya
    Bo, Jiang
    Lei, Su
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 389 - 394
  • [40] Study the Gene Expression of PIK3CA in Tissue and Blood Samples of Iraqi Patients with Colorectal Cancer
    Azeez, Rasha Abbas
    Al-Jowari, Suha Abdul-Khaliq
    Mahmood, Hayder Jamal
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2023, 9 (04): : 280 - 285